Skip to main content
Erschienen in: World Journal of Surgery 12/2005

01.12.2005

Liver Regeneration and Splenic Enlargement in Donors after Living-Donor Liver Transplantation

verfasst von: Salleh Ibrahim, MBBS Sing, FRCS Glas, Chao-Long Chen, MD, Chih-Chi Wang, MD, Shih-Ho Wang, MD, Chih-Che Lin, MD, Yeuh-Wei Liu, MD, Chin-Hsiang Yang, MD, Chee-Chien Yong, MD, Allan Concejero, MD, Yu-Fan Cheng, MD

Erschienen in: World Journal of Surgery | Ausgabe 12/2005

Einloggen, um Zugang zu erhalten

Abstract

Liver regeneration after donor hepactectomy offers a unique insight into the process of liver regeneration in normal livers. As the liver restores itself, concurrent splenic enlargement occurs. There are many theories about why this phenomenon takes place: some investigators have proposed a relative portal hypertension that leads to splenic congestion or, perhaps, the presence of a common growth factor that induces both the liver and spleen to enlarge. Between the months of June 2001 and May 2004, 112 live donor liver transplants (LDLTs) were performed in Chang Gung Memorial Hospital, Kaohsiung, Taiwan. The total number of donor hepatectomies performed during this period was 113, however, because one of the cases required dual donors. Of our 113 donors, we eventually analyzed the data of 109; 4 patients were lost to follow-up 6 months later and were excluded from our study. The average age of our donor population was 32.32 ± 8.48 years. The mean liver volume at donation was noted to be 1207.72 ± 219.95 cm3, and 6 months later, it was 1027.18 ± 202.41 cm3. Expressed as a percentage of the original volume, the mean liver volume 6 months after hepatectomy was 90.70% ± 12.47% in this series. For right graft donors, mean liver volume after 6 months was 89.68% ± 12.37% of the original liver volume, whereas that for left graft donors was 91.99% ± 12.6%. Only 26 of the 109 (23.85%) donors were able to achieve full regeneration 6 months post-donation. Notably, liver function profiles of all donors were normal when measured 6 months after operation. The average splenic volume at donation as measured by computed tomography (CT) volumetry was 159 ± 58 cm3, and the splenic volume 6 months post-donation was 213 ± 85 cm3. There was a mean increment in splenic volume of 35% ± 28% 6 months after donation. The blood profiles of the donors were monitored; particular attention was given to platelet levels and liver function tests, and these were found to be within normal limits 6 months after operation. Of note, splenic enlargement was significantly greater among right-sided donors than their left-sided counterparts. Greater splenic enlargement was also observed in those donors who achieved full liver regeneration at their evaluation 6 months postoperatively than in those who did not. Although original liver volume was not re-established in most patients 6 months after liver donation, there seemed to have been no untoward effects to the donor. The factors that affect liver regeneration are complex and myriad. Although there is splenic enlargement at 6 months post-donation in donors of LDLT, there are no untoward effects of this enlargement.
Literatur
1.
Zurück zum Zitat Nakagami M, Morimoto T, Itoh K, et al. Patterns of restoration of remnant liver volume after graft harvesting in donors for living related liver transplantation. Transplant. Proc. 1998;30:195–199CrossRefPubMed Nakagami M, Morimoto T, Itoh K, et al. Patterns of restoration of remnant liver volume after graft harvesting in donors for living related liver transplantation. Transplant. Proc. 1998;30:195–199CrossRefPubMed
2.
Zurück zum Zitat Nagasue N, Yukaya N, Ogawa Y, et al. Human liver regeneration after major hepatic resection. Ann Surg 1987;206:30PubMedCrossRef Nagasue N, Yukaya N, Ogawa Y, et al. Human liver regeneration after major hepatic resection. Ann Surg 1987;206:30PubMedCrossRef
3.
Zurück zum Zitat Tanaka W, Yamanaka N, Oriyama T, et al. Multivariate analysis of liver regenerative capacity after hepactectomy in humans. J. Hepatobil. Pancreat. Surg. 1997;4:78–82CrossRef Tanaka W, Yamanaka N, Oriyama T, et al. Multivariate analysis of liver regenerative capacity after hepactectomy in humans. J. Hepatobil. Pancreat. Surg. 1997;4:78–82CrossRef
4.
Zurück zum Zitat Yamanaka N, Okamoto E, Kawamura E, et al. Dynamics of normal and injured liver human liver regeneration after hepactectomy as assessed on the basis of computed tomography and liver function. Hepatology 1993;18:79–85CrossRefPubMed Yamanaka N, Okamoto E, Kawamura E, et al. Dynamics of normal and injured liver human liver regeneration after hepactectomy as assessed on the basis of computed tomography and liver function. Hepatology 1993;18:79–85CrossRefPubMed
5.
Zurück zum Zitat Bucher NH. Experimental aspects of hepatic regeneration. N. Engl. J. Med. 1967; 277:686PubMed Bucher NH. Experimental aspects of hepatic regeneration. N. Engl. J. Med. 1967; 277:686PubMed
6.
Zurück zum Zitat Fausto N. Liver regeneration: from laboratory to clinic. Liver Transplant. 2001;7:835CrossRef Fausto N. Liver regeneration: from laboratory to clinic. Liver Transplant. 2001;7:835CrossRef
7.
Zurück zum Zitat Court FG, Wemyss-Holden SA, Dennison AR, et al. The mystery of liver regeneration. Br. J. Surg. 2002;89:1089CrossRefPubMed Court FG, Wemyss-Holden SA, Dennison AR, et al. The mystery of liver regeneration. Br. J. Surg. 2002;89:1089CrossRefPubMed
8.
Zurück zum Zitat Olthoff KM. Molecular pathways of regeneration and repair after liver transplantation. World J. Surg. 2002;26:831CrossRefPubMed Olthoff KM. Molecular pathways of regeneration and repair after liver transplantation. World J. Surg. 2002;26:831CrossRefPubMed
9.
Zurück zum Zitat Marcos A, Fischer RA, Ham JM, et al. Liver regeneration and function in donor and recipient after right lobe adult to adult living donor liver transplantation. Transplantation 2000;69:1375–1379PubMedCrossRef Marcos A, Fischer RA, Ham JM, et al. Liver regeneration and function in donor and recipient after right lobe adult to adult living donor liver transplantation. Transplantation 2000;69:1375–1379PubMedCrossRef
10.
Zurück zum Zitat Pomfret EA, Pomposelli JJ, Gordon FD, et al. Liver regeneration and surgical outcome in donors of right lobe liver grafts. Transplantation 2003;76:5–10PubMedCrossRef Pomfret EA, Pomposelli JJ, Gordon FD, et al. Liver regeneration and surgical outcome in donors of right lobe liver grafts. Transplantation 2003;76:5–10PubMedCrossRef
11.
Zurück zum Zitat Kawasaki S, Makuuchi M, Matsunami H, et al. Living related liver transplantation in adults. Ann Surg 1998;227–269 Kawasaki S, Makuuchi M, Matsunami H, et al. Living related liver transplantation in adults. Ann Surg 1998;227–269
12.
Zurück zum Zitat Zollinger RM, Zollinger RM Jr. Left hepatic lobectomy. In Zollinger RM, Zollinger RM Jr, (editors), Atlas of Surgical Operations, 4th edition, New York, Macmillian, 1990; 172 Zollinger RM, Zollinger RM Jr. Left hepatic lobectomy. In Zollinger RM, Zollinger RM Jr, (editors), Atlas of Surgical Operations, 4th edition, New York, Macmillian, 1990; 172
13.
Zurück zum Zitat Akimaru K, Onda M, Tajiri T, et al. Hypersplenism induced by hepatectomy. Hepato-Gastroenterology 2001;48:1170–1175PubMed Akimaru K, Onda M, Tajiri T, et al. Hypersplenism induced by hepatectomy. Hepato-Gastroenterology 2001;48:1170–1175PubMed
14.
Zurück zum Zitat Ando H, Nagino M, Arai T, et al. Changes in splenic volume during liver regeneration. World J. Surg. 2004;28:977–981CrossRefPubMed Ando H, Nagino M, Arai T, et al. Changes in splenic volume during liver regeneration. World J. Surg. 2004;28:977–981CrossRefPubMed
15.
Zurück zum Zitat Tanaka W, Yamanaka N, Oriyama T. Multivariate analysis of liver regenerative capacity after hepactectomy in humans. J. Hepatobiliary Pancreatic Surg. 1997;4:78–82CrossRef Tanaka W, Yamanaka N, Oriyama T. Multivariate analysis of liver regenerative capacity after hepactectomy in humans. J. Hepatobiliary Pancreatic Surg. 1997;4:78–82CrossRef
16.
Zurück zum Zitat Miyagawa S, Kawasaki S, Noike T, et al. Liver regeneration after extended right hemihepactectomy in patients with hilar or diffuse bile duct carcinoma. Hepatogastroenterology 1999;46:364–368PubMed Miyagawa S, Kawasaki S, Noike T, et al. Liver regeneration after extended right hemihepactectomy in patients with hilar or diffuse bile duct carcinoma. Hepatogastroenterology 1999;46:364–368PubMed
17.
Zurück zum Zitat Nagino M, Ando M, Kamiya J, et al. Liver regeneration after major hepactectomy for biliary cancer. Br. J. Surg. 2001;88:1084–1091CrossRefPubMed Nagino M, Ando M, Kamiya J, et al. Liver regeneration after major hepactectomy for biliary cancer. Br. J. Surg. 2001;88:1084–1091CrossRefPubMed
18.
Zurück zum Zitat Jacob HS, Macdonald RA, Jandl JH. Regulation of spleen growth and sequestering function. J. Clin. Invest. 1963;42:1476–1490PubMedCrossRef Jacob HS, Macdonald RA, Jandl JH. Regulation of spleen growth and sequestering function. J. Clin. Invest. 1963;42:1476–1490PubMedCrossRef
19.
Zurück zum Zitat Tavassoli M. Limitation of splenic growth as studied by heterotopic splenic implants. Blood 1975;46:631–635PubMed Tavassoli M. Limitation of splenic growth as studied by heterotopic splenic implants. Blood 1975;46:631–635PubMed
20.
Zurück zum Zitat Chen YS, Cheng YF, De Villa VH, et al. Evaluation of living liver donors. Transplantation 2003;75(Suppl 3):S16–S19PubMedCrossRef Chen YS, Cheng YF, De Villa VH, et al. Evaluation of living liver donors. Transplantation 2003;75(Suppl 3):S16–S19PubMedCrossRef
21.
Zurück zum Zitat Chen CL, Chen YS, De Villa VH, et al. Minimal blood loss living donor hepatectomy. Transplantation 2000;69:2580–2586PubMedCrossRef Chen CL, Chen YS, De Villa VH, et al. Minimal blood loss living donor hepatectomy. Transplantation 2000;69:2580–2586PubMedCrossRef
22.
Zurück zum Zitat Greene AK, Wiener S, Puder M, et al. Endothelial directed hepatic regeneration after partial hepactectomy. Ann. Surg. 2002;236:530–534CrossRef Greene AK, Wiener S, Puder M, et al. Endothelial directed hepatic regeneration after partial hepactectomy. Ann. Surg. 2002;236:530–534CrossRef
23.
Zurück zum Zitat Francavilla A, Polimeno L, Dileo A, et al. The effect of estrogen and tamoxifen on hepatocyte proliferation in vivo and in vitro. Hepatology 1989;9–614 Francavilla A, Polimeno L, Dileo A, et al. The effect of estrogen and tamoxifen on hepatocyte proliferation in vivo and in vitro. Hepatology 1989;9–614
24.
Zurück zum Zitat Chiu J, Lin L, Chi W, et al. Estrogen therapy for hepactectomy with poor liver function? Med Hypotheses 2002;58:516CrossRefPubMed Chiu J, Lin L, Chi W, et al. Estrogen therapy for hepactectomy with poor liver function? Med Hypotheses 2002;58:516CrossRefPubMed
25.
Zurück zum Zitat Nagasue N, Yukaya H, Ogawa Y, et al. Portal pressure following partial to extensive hepatic resection in patients with and without cirrhosis of the liver. Ann. Chir. Gynecol. 1983;72:18–22 Nagasue N, Yukaya H, Ogawa Y, et al. Portal pressure following partial to extensive hepatic resection in patients with and without cirrhosis of the liver. Ann. Chir. Gynecol. 1983;72:18–22
26.
Zurück zum Zitat Ueda S, Yamanoi A, Hishikawa Y, et al. Transforming growth factor beta-1 released from the spleen exerts a growth inhibitory effect on liver regeneration in rats. Lab. Invest. 2003;83:1595–1603PubMedCrossRef Ueda S, Yamanoi A, Hishikawa Y, et al. Transforming growth factor beta-1 released from the spleen exerts a growth inhibitory effect on liver regeneration in rats. Lab. Invest. 2003;83:1595–1603PubMedCrossRef
27.
Zurück zum Zitat Kaido T, Oe H, Yoshikawa A, et al. Expressions of molecules associated with hepatocyte growth factor activation after hepatectomy in liver cirrhosis. Hepato-Gastroenterology 2004;51:547–551PubMed Kaido T, Oe H, Yoshikawa A, et al. Expressions of molecules associated with hepatocyte growth factor activation after hepatectomy in liver cirrhosis. Hepato-Gastroenterology 2004;51:547–551PubMed
28.
Zurück zum Zitat Charters AC, Oakes DD, Froechlich JP. Effect of hepatectomy on mitotic activity in rat spleen. J. Surg. Res. 1980;29:331–337CrossRefPubMed Charters AC, Oakes DD, Froechlich JP. Effect of hepatectomy on mitotic activity in rat spleen. J. Surg. Res. 1980;29:331–337CrossRefPubMed
29.
Zurück zum Zitat Rosenkranz E, Charters AC, Orloff MJ. Regeneration in rat liver injured by carbon tetrachloride. Surg. Forum 1975;26:411–412PubMed Rosenkranz E, Charters AC, Orloff MJ. Regeneration in rat liver injured by carbon tetrachloride. Surg. Forum 1975;26:411–412PubMed
30.
Zurück zum Zitat Tomiya T, Tani M, Yamada S, et al. Serum hepatocyte growth factor levels in hepactomised and nonhepactomised surgical patients. Gastroenterology 1992;103:1621–1624PubMed Tomiya T, Tani M, Yamada S, et al. Serum hepatocyte growth factor levels in hepactomised and nonhepactomised surgical patients. Gastroenterology 1992;103:1621–1624PubMed
31.
Zurück zum Zitat Nishizaki T, Takenaka K, Yoshizumi T, et al. Alteration in levels of human hepatocyte growth factor following hepactectomy. J. Am. Coll. Surg. 1995;181:6–10PubMed Nishizaki T, Takenaka K, Yoshizumi T, et al. Alteration in levels of human hepatocyte growth factor following hepactectomy. J. Am. Coll. Surg. 1995;181:6–10PubMed
32.
Zurück zum Zitat Sato K, Tanaka M, Tanikawa K. The effect of spleen volume on liver regeneration after hepatectomy—a clinical study of liver and spleen volumes by computed tomography. Hepatogastroenterology. 1995;42:961–965PubMed Sato K, Tanaka M, Tanikawa K. The effect of spleen volume on liver regeneration after hepatectomy—a clinical study of liver and spleen volumes by computed tomography. Hepatogastroenterology. 1995;42:961–965PubMed
Metadaten
Titel
Liver Regeneration and Splenic Enlargement in Donors after Living-Donor Liver Transplantation
verfasst von
Salleh Ibrahim, MBBS Sing, FRCS Glas
Chao-Long Chen, MD
Chih-Chi Wang, MD
Shih-Ho Wang, MD
Chih-Che Lin, MD
Yeuh-Wei Liu, MD
Chin-Hsiang Yang, MD
Chee-Chien Yong, MD
Allan Concejero, MD
Yu-Fan Cheng, MD
Publikationsdatum
01.12.2005
Erschienen in
World Journal of Surgery / Ausgabe 12/2005
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-005-0101-2

Weitere Artikel der Ausgabe 12/2005

World Journal of Surgery 12/2005 Zur Ausgabe

OriginalPaper

To the Editor

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.